Silverberg, Jonathan I.
Simpson, Eric L.
Armstrong, April W.
de Bruin-Weller, Marjolein S.
Irvine, Alan D.
Reich, Kristian
Article History
Accepted: 22 September 2021
First Online: 26 October 2021
Declarations
:
: Medical writing support was funded by LEO Pharma A/S, according to Good Publication Practice guidelines (ExternalRef removed). The authors received no honoraria related to the development of this publication.
: Jonathan I. Silverberg reports honoraria, as a consultant/advisory board member, from LEO Pharma and has acted as a consultant for and/or received grants/honoraria from AbbVie, AnaptysBio, Asana Biosciences, Galderma Research and Development, GSK, Glenmark, Kiniksa, LEO Pharma, Lilly, MedImmune, Menlo Therapeutics, Pfizer, PuriCore, Regeneron, and Sanofi. Eric L. Simpson is a consultant and investigator for AbbVie, Celgene, Dermira, Genentech, GSK, LEO Pharma, Lilly, MedImmune, Menlo Therapeutics, Pfizer, Regeneron, and Sanofi. April W. Armstrong is an investigator and/or consultant for AbbVie, Bristol Myers Squibb, Dermavant, Dermira, Janssen, Lilly, LEO Pharma, Modernizing Medicine, Ortho Dermatologics, Regeneron, Sanofi Genzyme, Science 37, and UCB. Marjolein S. de Bruin-Weller is a consultant/advisor for AbbVie, Lilly, Pfizer, Regeneron, Sanofi Genzyme, and UCB, and has received grant/research support from Regeneron and Sanofi Genzyme. Alan D. Irvine reports personal fees from AbbVie, Dermavant, Lilly, Pfizer, Regeneron, and Sanofi. Kristian Reich is a consultant/speaker/researcher for AbbVie, Affibody, Almirall, Amgen, Biogen, Boehringer Ingelheim, Celgene, Centocor, Covagen, Forward Pharma, Fresenius Medical Care, GSK, Janssen-Cilag, Kyowa Kirin, LEO Pharma, Lilly, Medac, Merck Sharp & Dohme, Miltenyi Biotec, Novartis, Ocean Pharma, Pfizer, Regeneron, Samsung Bioepis, Sanofi, Takeda, UCB, Valeant, and Xenoport.
: Anonymized raw survey data are available upon request.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors made substantial contributions to the concept and design of the manuscript, critically reviewed and revised the manuscript drafts, and provided final approval of the manuscript as submitted.